Zydus Cadila gets tentative US FDA nod for diabetes drug
The drug will be produced at the group's formulations manufacturing facility at special economic zone (SEZ), Ahmedabad
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Uttar Pradesh to open six pharma parks
Receives investment commitment of ₹ 50-60 billion
The Uttar Pradesh government is planning to open six pharma parks across the…
Domino Printech India: Reliable and economical solutions for wide range of applications
The company is an expert to full fill serialisation and aggregation needs
Domino is one of the world’s largest manufacturers of…
Doctors develop new technique to treat complex scar and wounds
The fundamental concept behind the technique is to eliminate the tension caused by local muscles on the wounds by temporary…
OPPI OTC task force releases Shaping India’s OTC Policy 2018
The study calls for a well-regulated OTC framework that not only helps improve access to medicines but also supports responsible…
Strand aims to carve out a unique niche in the area of clinical research
Dr Ramesh Hariharan, CEO, Strand Life Sciences, elaborates on his company’s future projects, growth strategies and more, in an…
Europe’s bio capacity forecast to overtake the US by 2022
According to CPhI Annual Report, the capacity growth will keep pace with demand over the next 5-years, but small companies may…
Winners of 2018 CPhI Pharma Awards announced
The awards, in their 15th edition, welcomed 365 guests to celebrate outstanding achievements in pharma across 17 different…
Lilly India launches Olumiant to treat rheumatoid arthritis
Olumiant will be available in India starting October 2018 in 4 mg and 2 mg dosage forms
Aurobindo Pharma receives US FDA approval for Azithromycin oral suspension
The product will be launched in November 2018
Aurobindo Pharma has received final approval from the US Food & Drug…